Cumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• AiRWA receives Nasdaq deficiency notice over late 10-K filing
• BofA sees mixed signals for European software from US SaaS